F15.151
Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F15.151 pertains to a specific mental health condition characterized by the abuse of stimulant substances leading to hallucinatory psychotic episodes. This condition involves individuals who have a pattern of misuse of stimulants—such as amphetamines, methamphetamines, or other related drugs—and subsequently experience psychosis marked by hallucinations. Recognizing this disorder is essential for effective healthcare provision and understanding the potential risks associated with stimulant misuse.
Causes & Symptoms
Clinical Causes: Prolonged use or high doses of stimulant substances, such as methamphetamine or cocaine. Patterns of abuse, including binge use or frequent consumption over extended periods. Underlying mental health vulnerabilities or predispositions that may influence susceptibility. Misuse of prescribed stimulant medications beyond therapeutic dosages.
Key Symptoms: Hallucinations, which can be visual, auditory, or tactile (feeling things that aren’t there). Paranoia or delusional thinking related to perceived threats or conspiracies. Agitation, restlessness, or unpredictable behavior. Disorganized thoughts or speech patterns. Severe mood changes, including episodes of paranoia or fear. Physical symptoms such as increased heart rate, elevated blood pressure, or hyperactivity.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough clinical assessment by a mental health professional, including a detailed history of substance use and mental state evaluation. Healthcare providers may utilize urine or blood tests to confirm recent stimulant use. Differential diagnosis helps to distinguish stimulant-induced psychosis from primary psychiatric disorders such as schizophrenia. No specific laboratory tests definitively identify the condition, but corroborative evidence from toxicology screens and psychiatric evaluation is crucial.
Treatment Protocols: Detoxification: Medical supervision during withdrawal to manage physical symptoms and prevent complications. Psychiatric support: Medications may be used to address psychotic symptoms temporarily, such as antipsychotics, while working through substance abuse treatment. Substance abuse counseling: Behavioral therapies like cognitive-behavioral therapy (CBT) help address the underlying patterns of stimulant misuse. Comprehensive rehabilitation programs: Combining therapy, support groups, and supervision to promote sustained recovery. Addressing underlying mental health conditions: Treatment plans may include therapy for coexisting disorders like anxiety or depression. Relapse prevention strategies: Education about triggers, development of coping skills, and ongoing support are essential for long-term recovery.
Clinical Advice & FAQs
Billing Guidance
Is F15.151 a billable ICD-10 code?
Yes, F15.151 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.151?
Clinical documentation must specify the nature of Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations and any associated comorbidities for accurate reporting.
Cite this Clinical Reference